$TPAC For Traders and Investors Alike: I wanted to give

New Post Public Reply Private Reply Replies (0) Message Board
Mysterium
304
$TPAC For Traders and Investors Alike:
I wanted to give everyone an alert on a run I see coming up. A few years back TPAC ran from .0004-.0072. I believe that is gearing up again. I'll explain why.

To get the simple stuff out of the way, there is only about $15k between .0001 and a 100% move to .0002. It varies by a few grand here and there, but is getting whittled down day by day. Also, there is a trading group on this already. They are all over Twitter. And on Ihub, if you look at the guys on the board, then cross reference those names with the list of moderators on the ADAC board, you'll catch my drift.

From a more substantial point of reference, the company has three ICOs coming out. The first one, an ebike ICO, being marketed to both retail and city govts, is going to have a coin that is a registered security, as well as an additional coin that is a utility coin for ride sharing. The CEO is quoted saying that the ICO will be $30M, and 20%, or $6M, will be allocated for share buyback. That is enough to buy back the entire O/S a few times over here, so making at least 100% from .0001 will be easy.

The second of the two ICOs will be an aerospace supply chain and quality control product using blockchain application. The CEO is a partner at ICO Advisory Services. This is being done correctly, and with an experienced team.

The third ICO will come out after a wind farm acquisition, which is slated to close within 30-90 days. The ICO will add extra megawatts and will be used for the privatized sale of renewable energy in Europe.

The ebikes are also a product for TPAC. In a post on another investment site, the CEO mentioned that selling 20,000 bikes in a year was very doable. The revenues from that would be $14M. Again, we are at .0001.

Now, here's where it gets better. TPAC just become the exclusive supplier for Onebot Global ebikes in North America. They now have better rates on the bike, as well as international support, and they are projecting 10-25k bikes sold per month. Remember from the paragraph above, 20k bikes per year would equate to $14M. Mid-range of the aforementioned figures, we're now looking at ten times that revenue number. The ICOs will be non-dilutive and will count as revenue/assets for the company. So again, the current pps is .0001.

Lastly, there is an extra horse in the race, a trading firm out of Baltimore assisting with share absorption. They mentioned on their private Twitter acct today that they would be absorbing shares through Q2. The ebike ICO pre-funds in Q1, and then funds the rest of the way via the public market in Q2. It is my assumption that this firm is buying the shares and holding them, and once the ICO revs are made, the shares will be repurchased from the trading firm by TPAC and will then be removed from both the O/S and the A/S.

It was mentioned in a filing that this was going to happen quite some time ago. I saved that filing(see 8.01): filings.irdirect.net/data/1422295/000168316816000428/tpac_8k.pdf

There is a ton more info, and I am just scratching the surface, so for more, go to Twitter and check out https://twitter.com/TPACbearings/with_replies

Enjoy the gains!

Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading